Download PDF
Aktuelle Ernährungsmedizin 2007; 32: S60-S68
DOI: 10.1055/s-2006-951888
Leitlinie Parenterale Ernährung der DGEM
© Georg Thieme Verlag KG Stuttgart · New York

11 Komplikationen und Monitoring

W.  Hartl (AG-Leiter), K.  W.  Jauch, K.  Parhofer, P.  Rittler
Further Information

Publication History

Publication Date:
04 March 2008 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Refeeding-Syndrom - Hyperglykämie - Hypertriglyzeridämie - Hepatopathie - Katheterinfektion

Key words

refeeding syndrome - hyperglycaemia - hypertriglyceridaemia - liver disease - catheter infection

Literatur

  • 1 ASPEN Bord of Directors and The Clinical Guidelines Task Force . Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients.  JPEN J Parenter Enteral Nutr. 2002;  26 1SA-138SA
    CrossrefPubMedGoogle Scholar
  • 2 Maroulis J, Kalfarentzos F. Complications of parenteral nutrition at the end of the century.  Clin Nutr. 2000;  19 295-304
    CrossrefPubMedGoogle Scholar
  • 3 Koretz R L, Lipman T O, Klein S. AGA technical review on parenteral nutrition.  Gastroenterology. 2001;  121 970-1001
    PubMedGoogle Scholar
  • 4 Braunschweig C L, Levy P, Sheean P M, Wang X. Enteral compared with parenteral nutrition: a meta-analysis.  Am J Clin Nutr. 2001;  74 534-542
    CrossrefPubMedGoogle Scholar
  • 5 Berghe G van den. Insulin therapy for the critically ill patient.  Clin Cornerstone. 2003;  5 56-63
    CrossrefPubMedGoogle Scholar
  • 6 Marik P E, Pinsky M. Death by parenteral nutrition.  Intensive Care Med. 2003;  29 867-869
    PubMedGoogle Scholar
  • 7 Anderson A D, Jain P K, MacFie J. Parenteral nutrition in the critically ill.  Intensive Care Med. 2003;  29 2103
    CrossrefPubMedGoogle Scholar
  • 8 Fürst P. Comment on „Death by parenteral nutrition” by Marik and Pinsky.  Intensive Care Med. 2003;  29 2102
    CrossrefPubMedGoogle Scholar
  • 9 Varga P, Griffiths R, Chiolero R. et al . Is parenteral nutrition guilty?.  Intensive Care Med. 2003;  29 1861-1864
    CrossrefPubMedGoogle Scholar
  • 10 Alpers D H. Enteral feeding and gut atrophy.  Curr Opin Clin Nutr Metab Care. 2002;  5 679-683
    CrossrefPubMedGoogle Scholar
  • 11 Bistrian B R. Update on total parenteral nutrition.  Am J Clin Nutr. 2001;  74 153-154
    PubMedGoogle Scholar
  • 12 Jeejeebhoy K N. Total parenteral nutrition: potion or poison?.  Am J Clin Nutr. 2001;  74 160-163
    PubMedGoogle Scholar
  • 13 Richards D M, Deeks J J, Sheldon T A, Shaffer J L. Home parenteral nutrition: a systematic review.  Health Technol Assess. 1997;  1 1-59
    PubMedGoogle Scholar
  • 14 Klein S. A primer of nutritional support for gastroenterologists.  Gastroenterology. 2002;  122 1677-1687
    CrossrefPubMedGoogle Scholar
  • 15 Buchman A L, Moukarzel A A, Bhuta S. et al . Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.  JPEN J Parenter Enteral Nutr. 1995;  19 453-460
    PubMedGoogle Scholar
  • 16 Guedon C, Schmitz J, Lerebours E. et al . Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults.  Gastroenterology. 1986;  90 373-378
    PubMedGoogle Scholar
  • 17 Pironi L, Paganelli G M, Miglioli M. et al . Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection.  JPEN J Parenter Enteral Nutr. 1994;  18 351-354
    CrossrefPubMedGoogle Scholar
  • 18 Sedman P C, MacFie J, Palmer M D, Mitchell C J, Sagar P M. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans.  Br J Surg. 1995;  82 1663-1667
    CrossrefPubMedGoogle Scholar
  • 19 Hulst R R van der, Kreel B K van, Meyenfeldt M F von. et al . Glutamine and the preservation of gut integrity.  Lancet. 1993;  341 1363-1365
    CrossrefPubMedGoogle Scholar
  • 20 Hulst R R van der, Meyenfeldt M F von, Tiebosch A, Buurman W A, Soeters P B. Glutamine and intestinal immune cells in humans.  JPEN J Parenter Enteral Nutr. 1997;  21 310-315
    PubMedGoogle Scholar
  • 21 Hulst R R van der, Meyenfeldt M F von, Deutz N E, Stockbrugger R W, Soeters P B. The effect of glutamine administration on intestinal glutamine content.  J Surg Res. 1996;  61 30-34
    CrossrefPubMedGoogle Scholar
  • 22 Ahlman B, Ljungqvist O, Persson B, Bindslev L, Wernerman J. Intestinal amino acid content in critically ill patients.  JPEN J Parenter Enteral Nutr. 1995;  19 272-278
    PubMedGoogle Scholar
  • 23 Hadfield R J, Sinclair D G, Houldsworth P E, Evans T W. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill.  Am J Respir Crit Care Med. 1995;  152 1545-1548
    CrossrefPubMedGoogle Scholar
  • 24 No authors listed. Safe Practices for Parenteral Nutrition Formulations. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition.  JPEN J Parenter Enteral Nutr. 1998;  22 49-66
    PubMedGoogle Scholar
  • 25 Llop J, Sabin P, Garau M. et al . The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia.  Clin Nutr. 2003;  22 577-583
    CrossrefPubMedGoogle Scholar
  • 26 Finney S J, Zekveld C, Elia A, Evans T W. Glucose control and mortality in critically ill patients.  JAMA. 2003;  290 2041-2047
    CrossrefPubMedGoogle Scholar
  • 27 Malmberg K. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.  BMJ. 1997;  314 1512-1515
    CrossrefPubMedGoogle Scholar
  • 28 Meier J J, Deifuß S, Gallwitz B, Klamann A, Schmiegel W, Nauck M A. Einfluss einer eingeschränkten Glukosetoleranz auf das Langzeitüberleben nach akutem Myokardinfarkt.  Dtsch Med Wochenschr. 2002;  127 1123-1129
    PubMedGoogle Scholar
  • 29 Norhammar A M, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.  Diabetes Care. 1999;  22 1827-1831
    CrossrefPubMedGoogle Scholar
  • 30 Parsons M W, Barber P A, Desmond P M. et al . Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.  Ann Neurol. 2002;  52 20-28
    CrossrefPubMedGoogle Scholar
  • 31 Umpierrez G E, Isaacs S D, Bazargan N, You X, Thaler L M, Kitabchi A E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.  J Clin Endocrinol Metab. 2002;  87 978-982
    CrossrefPubMedGoogle Scholar
  • 32 Berghe G van den, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367
    CrossrefPubMedGoogle Scholar
  • 33 Weir C J, Murray G D, Dyker A G, Lees K R. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.  BMJ. 1997;  314 1303-1306
    CrossrefPubMedGoogle Scholar
  • 34 Zindrou D, Taylor K M, Bagger J P. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting.  Diabetes Care. 2001;  24 1634-1639
    CrossrefPubMedGoogle Scholar
  • 35 Kim H, Son E, Kim J. et al . Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition.  Am J Health Syst Pharm. 2003;  60 1760-1766
    PubMedGoogle Scholar
  • 36 Angelico M, Della G P. Review article: hepatobiliary complications associated with total parenteral nutrition.  Aliment Pharmacol Ther. 2000;  14, Suppl 2 54-57
    CrossrefPubMedGoogle Scholar
  • 37 Chung C, Buchman A L. Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction.  Clin Liver Dis. 2002;  6 1067-1084
    CrossrefPubMedGoogle Scholar
  • 38 Adamkin D H. Total parenteral nutrition-associated cholestasis: prematurity or amino acids?.  J Perinatol. 2003;  23 437-438
    CrossrefPubMedGoogle Scholar
  • 39 Forchielli M L, Walker W A. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition.  Adv Pediatr. 2003;  50 245-267
    PubMedGoogle Scholar
  • 40 Sandhu I S, Jarvis C, Everson G T. Total parenteral nutrition and cholestasis.  Clin Liver Dis. 1999;  3 489-508, viii
    CrossrefPubMedGoogle Scholar
  • 41 Gleghorn E E, Merritt R J, Subramanian N, Ramos A. Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates.  JPEN J Parenter Enteral Nutr. 1986;  10 282-283
    PubMedGoogle Scholar
  • 42 Spagnuolo M I, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.  Gastroenterology. 1996;  111 716-719
    CrossrefPubMedGoogle Scholar
  • 43 Spurr S G, Grylack L J, Mehta N R. Hyperalimentation-associated neonatal cholestasis: effect of oral gentamicin.  JPEN J Parenter Enteral Nutr. 1989;  13 633-636
    PubMedGoogle Scholar
  • 44 Buchman A L. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.  Dig Dis Sci. 2001;  46 1-18
    CrossrefPubMedGoogle Scholar
  • 45 Doty J E, Pitt H A, Porter-Fink V, Denbesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.  Ann Surg. 1985;  201 76-80
    PubMedGoogle Scholar
  • 46 Kalfarentzos F, Vagenas C, Michail A. et al . Gallbladder contraction after administration of intravenous amino acids and long-chain triacylglycerols in humans.  Nutrition. 1991;  7 347-349
    PubMedGoogle Scholar
  • 47 Sitzmann J V, Pitt H A, Steinborn P A, Pasha Z R, Sanders R C. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.  Surg Gynecol Obstet. 1990;  170 25-31
    PubMedGoogle Scholar
  • 48 Cohen-Solal M, Baudoin C, Joly F. et al . Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study.  J Bone Miner Res. 2003;  18 1989-1994
    CrossrefPubMedGoogle Scholar
  • 49 Nishikawa R A. Intravenous pamidronate improves bone mineral density in home parenteral nutrition patients.  Clin Nutr. 2003;  22, Suppl 1 88
    PubMedGoogle Scholar
  • 50 Kaminski Jr M V. A review of hypersomolar hyperglycemic nonketotic dehydration (HHND): etiology, pathophysiology and prevention during intravenous hyperalimentation.  JPEN J Parenter Enteral Nutr. 1978;  2 690-698
    CrossrefPubMedGoogle Scholar
  • 51 Rosmarin D K, Wardlaw G M, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose.  Nutr Clin Pract. 1996;  11 151-156
    CrossrefPubMedGoogle Scholar
  • 52 Owens J P, Geibig C B, Mirtallo J M. Concurrent quality assurance for a nutrition-support service.  Am J Hosp Pharm. 1989;  46 2469-2476
    PubMedGoogle Scholar
  • 53 Grünert A. Überwachung der Patienten mit Ernährungstherapie - Biophysikalische und biochemische Meßgrößen.  Klin Anästhesiol Intensivther. 1990;  40 193-195
    PubMedGoogle Scholar
  • 54 Seidner D L. Parenteral nutrition-associated metabolic bone disease.  JPEN J Parenter Enteral Nutr. 2002;  26 S37-S42
    PubMedGoogle Scholar
  • 55 Kelly D G. Guidelines and available products for parenteral vitamins and trace elements.  JPEN J Parenter Enteral Nutr. 2002;  26 S34-S36
    PubMedGoogle Scholar